Effects of strontium ranelate administration on bisphosphonate-altered hydroxyapatite: Matrix incorporation of strontium is accompanied by changes in mineralization and microstructure

Felsenberg, 2005, The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management, Clin Ther, 27, 1, 10.1016/j.clinthera.2004.12.020 Seeman, 2006, Bone quality—the material and structural basis of bone strength and fragility, N Engl J Med, 354, 2250, 10.1056/NEJMra053077 Busse, 2009, Increased calcium content and inhomogeneity of mineralization render bone toughness in osteoporosis: mineralization, morphology and biomechanics of human single trabeculae, Bone, 45, 1034, 10.1016/j.bone.2009.08.002 Hernandez, 2006, A biomechanical perspective on bone quality, Bone, 39, 1173, 10.1016/j.bone.2006.06.001 Djuric, 2010, Region-specific sex-dependent pattern of age-related changes of proximal femoral cancellous bone and its implications on differential bone fragility, Calcif Tissue Int, 86, 192, 10.1007/s00223-009-9325-8 Arlot, 2008, Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate, J Bone Miner Res, 23, 215, 10.1359/jbmr.071012 Bilezikian, 2009, Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis, Am J Med, 122, S14, 10.1016/j.amjmed.2008.12.003 Torgerson, 2001, Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials, JAMA, 285, 2891, 10.1001/jama.285.22.2891 Ensrud, 2008, Effects of raloxifene on fracture risk in postmenopausal women: the raloxifene use for the heart trial, J Bone Miner Res, 23, 112, 10.1359/jbmr.070904 Neer, 2001, Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis, N Engl J Med, 344, 1434, 10.1056/NEJM200105103441904 Meunier, 2004, The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis, N Engl J Med, 350, 459, 10.1056/NEJMoa022436 Reginster, 2005, Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study, J Clin Endocrinol Metab, 90, 2816, 10.1210/jc.2004-1774 Reginster, 2008, Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: results of a five-year, randomized, placebo-controlled trial, Arthritis Rheum, 58, 1687, 10.1002/art.23461 Baron, 2002, In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation, Eur J Pharmacol, 450, 11, 10.1016/S0014-2999(02)02040-X Canalis, 1996, The divalent strontium salt strontium ranelate enhance bone cell replication and bone formation in vitro, Bone, 18, 517, 10.1016/8756-3282(96)00080-4 Takahashi, 2003, S12911-2 inhibits osteoclastic bone resorption in vitro, J Bone Miner Res, 18, 1082, 10.1359/jbmr.2003.18.6.1082 Middleton, 2010, The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate, J Bone Miner Res, 25, 455, 10.1359/jbmr.090821 Jamshidi, 1971, Bone marrow biopsy with unaltered architecture: a new biopsy device, J Lab Clin Med, 77, 335 Blake, 2007, Effect of bone strontium on BMD measurements, J Clin Densitom, 10, 34, 10.1016/j.jocd.2006.10.004 Blake, 2005, Long-term effect of strontium ranelate treatment on BMD, J Bone Miner Res, 20, 1901, 10.1359/JBMR.050810 Blake, 2007, A review of strontium ranelate and its effect on DXA scans, J Clin Densitom, 10, 113, 10.1016/j.jocd.2007.01.002 Hahn, 1991, Undecalcified preparation of bone tissue: report of technical experience and development of new methods, Virchows Arch A Pathol Anat Histopathol, 418, 1, 10.1007/BF01600238 Donath, 1982, A method for the study of undecalcified bones and teeth with attached soft tissues. The Säge–Schliff (sawing and grinding) technique, J Oral Pathol, 11, 318, 10.1111/j.1600-0714.1982.tb00172.x Haschke, 2006, Micro-XRF excitation in an SEM, X-Ray Spectrom, 36, 254, 10.1002/xrs.974 Bjeoumikhov, 2005, A new microfocus X-ray source, iMOXS, for highly sensitive XRF analysis in scanning electron microscopes, X-Ray Spectrom, 34, 493, 10.1002/xrs.872 Parfitt, 1987, Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee, J Bone Miner Res, 2, 595, 10.1002/jbmr.5650020617 Seitz, 2010, High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1, Osteoporos Int, 21, 119, 10.1007/s00198-009-0933-y Roschger, 2008, Bone mineralization density distribution in health and disease, Bone, 42, 456, 10.1016/j.bone.2007.10.021 Skedros, 1993, Influence of mineral content and composition on graylevels in backscattered electron images of bone, J Biomed Mater Res, 27, 57, 10.1002/jbm.820270108 Roschger, 1995, A new scanning electron microscopy approach to the quantification of bone mineral distribution: backscattered electron image grey-levels correlated to calcium K alpha-line intensities, Scanning Microsc, 9, 75 Roschger, 1998, Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies, Bone, 23, 319, 10.1016/S8756-3282(98)00112-4 Ammann, 2004, Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats, J Bone Miner Res, 19, 2012, 10.1359/jbmr.040906 Lips, 2001, Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications, Endocr Rev, 22, 477, 10.1210/edrv.22.4.0437 Chavassieux, 1997, Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis, J Clin Invest, 100, 1475, 10.1172/JCI119668 Recker, 2004, Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study, Osteoporos Int, 15, 231, 10.1007/s00198-003-1530-0 Hwang, 2008, The effects of strontium ranelate in Asian women with postmenopausal osteoporosis, Calcif Tissue Int, 83, 308, 10.1007/s00223-008-9180-z Marie, 1993, An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats, J Bone Miner Res, 8, 607, 10.1002/jbmr.5650080512 Zhu, 2007, Induction of a program gene expression during osteoblast differentiation with strontium ranelate, Biochem Biophys Res Commun, 355, 307, 10.1016/j.bbrc.2007.01.120 Black, 2006, FLEX research group. Effects of continuing or stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extension (FLEX): a randomized trial, JAMA, 296, 2927, 10.1001/jama.296.24.2927 Fuchs, 2008, Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats, J Bone Miner Res, 23, 1689, 10.1359/jbmr.080501 Nielsen, 1999, Influence of strontium on bone mineral density and bone mineral content measurements by dual X-ray absorptiometry, J Clin Densitom, 2, 371, 10.1016/S1094-6950(06)60402-2 Kendler, 2009, Monitoring strontium ranelate therapy in patients with osteoporosis, Osteoporos Int, 20, 1101, 10.1007/s00198-009-0886-1 Boivin, 2006, Bone strontium distribution and degree of mineralization of bone in postmenopausal osteoporotic women treated with strontium ranelate for 2 and 3 years, Calcif Tissue Int, 78, S36 Bruyere, 2007, Relation between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate, J Clin Endocrinol Metab, 92, 3076, 10.1210/jc.2006-2758 Roschger P, Manjubala I, Zoeger N, Meirer F, Simon R, Li C, Fratzl-Zelman N, Misof B, Paschalis E, Streli C, Fratzl P, Klaushofer K. Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3 years strontium ranelate treatment. J Bone Miner Res. 2009, Oct 19. [Epub ahead of print]. Fratzl, 1996, Effects of sodium fluoride and alendronate on the bone mineral in minipigs: a small-angle X-ray scattering and backscattered electron imaging study, J Bone Miner Res, 11, 248, 10.1002/jbmr.5650110214 Farlay, 2005, Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone, J Bone Miner Res, 20, 1569, 10.1359/JBMR.050405 Boivin, 2010, In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization, Osteoporos Int, 21, 667, 10.1007/s00198-009-1005-z Li, 2009, Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment, J Bone Miner Res., 29 Fuchs, 2008, Strontium ranelate does not stimulate bone formation in ovariectomized rats, Osteoporos Int, 19, 1331, 10.1007/s00198-008-0602-6 Bain, 2009, Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants, Osteoporos Int, 20, 1417, 10.1007/s00198-008-0815-8 Ammann, 2007, Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength, J Bone Miner Res, 22, 1419, 10.1359/jbmr.070607 Busse, 2006, Fluorosis a forgotten entity. Case report of a woman with coxarthrosis and newly diagnosed fluorosis, Pathologe, 27, 73, 10.1007/s00292-005-0799-5 Busse, 2008, Allocation of nonbirefringent wear debris: darkfield illumination associated with PIXE microanalysis reveals cobalt deposition in mineralized bone matrix adjacent to CoCr implants, J Biomed Mater Res A, 87, 536, 10.1002/jbm.a.31794